In a study by Devasahayam et al. [109], no differences were reported in BDNF levels at rest between patients with multiple sclerosis (MS) and controls; however, IL-6 levels were significantly higher in patients with MS. The gene discussed is BDNF; the disease is myeloid sarcoma.